Highbridge Capital Management’s OnKure Therapeutics, Inc. Class A Common Stock OKUR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.59M | Buy |
663,607
+224,810
| +51% | +$537K | 0.06% | 95 |
|
|
2025
Q1 | $1.89M | Buy |
438,797
+39,054
| +10% | +$168K | 0.08% | 78 |
|
|
2024
Q4 | $3.44M | Buy |
399,743
+93,474
| +31% | +$804K | 0.13% | 96 |
|
|
2024
Q3 | $5.21M | Buy |
306,269
+14,731
| +5% | +$250K | 0.17% | 89 |
|
|
2024
Q2 | $4.4M | Buy |
291,538
+17,881
| +7% | +$270K | 0.14% | 76 |
|
|
2024
Q1 | $4.54M | Buy |
273,657
+161,487
| +144% | +$2.68M | 0.17% | 79 |
|
|
2023
Q4 | $1.79M | Buy |
+112,170
| New | +$1.79M | 0.07% | 81 |
|